About The Taube Koret Center

The goal of the Taube-Koret Center for Huntington’s Disease Research (TKC) is to establish a translational research and development center that will undertake an ambitious and integrated program (“HD CURE 2020”) to prevent, treat, and cure Huntington’s disease (HD) by 2020. The program will achieve this goal with an innovative program that targets a critical gap between the discovery of putative targets, which typically occurs in academia, and the development of safe and effective drugs, which requires the resources and expertise of industry. The TKC HD research program will consist of a target validation and drug development program and a target/drug discovery program. Both will benefit from access to experienced individuals with extensive industrial and drug development expertise and to highly experienced Contract Research Organization (CRO) providers.